News Less-Frequent Injected Drug Works in Wet Macular Degeneration by Medscape • 2010/11/25 • 0 Comments Regeneron Pharmaceuticals Inc's treatment for wet macular degeneration was as effective and safe in two late-stage trials as Roche Holding AG's blockbuster Lucentis, with half the number of eye injections. Reuters Health Information Full Story →